Cypress Capital Group has filed its 13F form on July 25, 2024 for Q2 2024 where it was disclosed a total value porftolio of $827 Million distributed in 489 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Eli Lilly & CO with a value of $50.9M, Ishares Core S&P 500 ETF with a value of $49.8M, Apple Inc. with a value of $45.1M, Microsoft Corp with a value of $37.8M, and Visa Inc. with a value of $19.6M.

Examining the 13F form we can see an decrease of $1.44M in the current position value, from $828M to 827M.

Below you can find more details about Cypress Capital Group portfolio as well as his latest detailed transactions.

Portfolio value $827 Million
Technology: $165 Million
ETFs: $157 Million
Healthcare: $138 Million
Financial Services: $83 Million
Consumer Cyclical: $63.3 Million
Industrials: $59.9 Million
Energy: $50.5 Million
Consumer Defensive: $48.8 Million
Other: $61.5 Million

Stock Holdings Table Market Cap. of Under $50 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 489
  • Current Value $827 Million
  • Prior Value $828 Million
  • Filing
  • Period Q2 2024
  • Filing Date July 25, 2024
  • Form Type 13F-HR
  • Activity in Q2 2024
  • New Purchases 16 stocks
  • Additional Purchases 61 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 185 stocks
Track This Portfolio

Track Cypress Capital Group Portfolio

Follow Cypress Capital Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cypress Capital Group, based on Form 13F filings with the SEC.

News

Stay updated on Cypress Capital Group with notifications on news.